81170 Abl1 gene
Also known as: ABL1 gene testing, Philadelphia chromosome detection
Molecular analysis to detect mutations in the ABL1 gene, most commonly associated with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia.
In Plain Language
chronic leukemia gene test; blood cancer mutation screening
Clinical Context
Ordered to confirm BCR-ABL1 fusion in chronic myeloid leukemia for disease confirmation and to guide tyrosine kinase inhibitor therapy selection and monitoring.
RVU Information
CPT 81170 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81170?
CPT 81170 (Abl1 gene) is a Pathology & Lab code. Molecular analysis to detect mutations in the ABL1 gene, most commonly associated with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia.
Who uses CPT code 81170?
CPT 81170 is used by Oncology, Hematology, Pathology. Ordered to confirm BCR-ABL1 fusion in chronic myeloid leukemia for disease confirmation and to guide tyrosine kinase inhibitor therapy selection and monitoring.
When is CPT 81170 used?
Ordered to confirm BCR-ABL1 fusion in chronic myeloid leukemia for disease confirmation and to guide tyrosine kinase inhibitor therapy selection and monitoring.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.